top of page
Search

Neuroendocrine Tumors & Carcinoid Syndrome

TL;DR

Neuroendocrine Tumors & Carcinoid Syndrome are high-yield topics for MRCP Part 1, commonly testing serotonin metabolism, 5-HIAA interpretation, and right-sided cardiac complications. Focus on recognising the classic triad, understanding when symptoms occur (especially with liver metastases), and knowing octreotide as first-line therapy. Expect integrated questions linking pathology, biochemistry, and clinical findings.


Why this matters

Within MRCP Part 1, neuroendocrine tumours (NETs) are repeatedly tested because they combine physiology, oncology, and pharmacology in a single topic. Candidates are expected to recognise carcinoid syndrome, select the correct diagnostic test, and identify complications such as carcinoid heart disease.

A structured understanding of this topic will improve accuracy in single-best-answer questions. Begin your revision with the MRCP Part 1 overview and reinforce concepts using Free MRCP MCQs.


Core sections

1. What are Neuroendocrine Tumours (NETs)?

Neuroendocrine tumours arise from enterochromaffin cells, which possess both neural and endocrine features.

Common primary sites:

  • Gastrointestinal tract (especially terminal ileum)

  • Pancreas

  • Bronchial tree

NETs are classified as:

  • Functioning tumours → secrete hormones (e.g., serotonin)

  • Non-functioning tumours → present late due to mass effect

Exam insight: Small intestinal NETs are the most common cause of carcinoid syndrome in MRCP questions.

2. Pathophysiology of Carcinoid Syndrome

Carcinoid syndrome results from systemic release of vasoactive mediators:

  • Serotonin (5-HT)

  • Bradykinin

  • Histamine

Under normal conditions:

  • Serotonin is metabolised in the liver → no systemic effects

Symptoms occur when:

  • There are hepatic metastases, or

  • Tumours bypass portal circulation (e.g., bronchial NETs)

Key mechanism: Excess tryptophan is diverted to serotonin → leading to niacin deficiency (pellagra).

3. Clinical Features (Classic Triad)

The hallmark triad includes:

  1. Flushing (episodic, reddish-purple)

  2. Diarrhoea

  3. Bronchospasm (wheeze)

Additional features:

  • Abdominal pain

  • Weight loss

  • Pellagra (dermatitis, diarrhoea, dementia)

4. Investigations (High-Yield Table)

Investigation

Purpose

MRCP relevance

24-hour urinary 5-HIAA

Measures serotonin metabolite

Most important diagnostic test

Plasma chromogranin A

Tumour marker

Monitoring disease

CT/MRI abdomen

Localisation and staging

Standard imaging

Ga-68 DOTATATE PET

Somatostatin receptor imaging

Highly sensitive

Echocardiography

Detects valvular lesions

Carcinoid heart disease

Exam tip: Avoid false positives in 5-HIAA—foods like bananas, pineapples, and drugs (e.g., SSRIs) can interfere.

5. Management Overview

First-line therapy:

  • Somatostatin analogues:

    • Octreotide

    • Lanreotide

Other treatments:

  • Surgical resection (if localised)

  • Hepatic artery embolisation (for liver metastases)

  • Peptide receptor radionuclide therapy (PRRT)

Carcinoid crisis (exam favourite):

  • Trigger: surgery or tumour manipulation

  • Treatment: IV octreotide

6. Carcinoid Heart Disease

Occurs due to prolonged serotonin exposure:

  • Right-sided valves affected:

    • Tricuspid regurgitation

    • Pulmonary stenosis

Why right-sided?

  • Serotonin is metabolised in the lungs → protects left heart

Clinical clue: Murmur + flushing + diarrhoea strongly suggests carcinoid syndrome.

7. Five Most Tested Subtopics

  1. Interpretation of 5-HIAA

  2. Mechanism of flushing

  3. Right-sided valvular disease

  4. Role of somatostatin analogues

  5. Carcinoid crisis management

8. High-Yield Rapid Recall (Numbered List)

  1. Small bowel NETs → most common cause

  2. Liver metastasis required for systemic symptoms

  3. 5-HIAA = gold-standard test

  4. Dietary restrictions before testing

  5. Classic triad: flushing, diarrhoea, wheeze

  6. Right-sided heart lesions dominate

  7. Octreotide = first-line treatment

  8. IV octreotide treats carcinoid crisis

  9. Chromogranin A for monitoring

  10. Bronchial NETs bypass liver metabolism


Practical examples / mini-cases

MCQ Example

A 58-year-old woman presents with intermittent flushing and chronic diarrhoea. On examination, she has a systolic murmur best heard at the lower left sternal border.

Which investigation is most appropriate to confirm the diagnosis?

A. Serum calcitoninB. Plasma metanephrinesC. 24-hour urinary 5-HIAAD. Serum gastrinE. Urinary VMA

Answer: C. 24-hour urinary 5-HIAA

Explanation: This presentation is classic for carcinoid syndrome with right-sided valvular involvement. The most specific and commonly tested diagnostic test is urinary 5-HIAA.


Common pitfalls (5 bullets)

  • Assuming carcinoid syndrome occurs without liver metastasis

  • Forgetting dietary restrictions before 5-HIAA testing

  • Confusing carcinoid flushing with menopause or mastocytosis

  • Missing right-sided heart involvement as a diagnostic clue

  • Not recognising carcinoid crisis as a medical emergency


Practical study-tip checklist

  • □ Learn 5-HIAA indications and limitations

  • □ Link liver metastases with systemic symptoms

  • □ Revise cardiac complications (right-sided valves)

  • □ Memorise octreotide uses (chronic + crisis)

  • □ Practise questions using Free MRCP MCQs

  • □ Attempt timed exams via Start a mock test

  • □ Review related GI topics (see Gastroenterology high-yield notes)

Medical student revising neuroendocrine tumours and carcinoid syndrome notes for MRCP Part 1 exam preparation

FAQs

1. Why does carcinoid syndrome usually require liver metastases?

Because serotonin is normally metabolised in the liver. When metastases occur, serotonin bypasses metabolism and enters systemic circulation.

2. What is the most important diagnostic test?

A 24-hour urinary 5-HIAA measurement is the most specific and frequently tested investigation.

3. Why is only the right side of the heart affected?

Serotonin is inactivated in the lungs, protecting the left side of the heart.

4. What is carcinoid crisis?

A life-threatening surge of vasoactive substances triggered by stress or surgery, treated with IV octreotide.

5. What is chromogranin A used for?

It is mainly used for monitoring tumour progression rather than initial diagnosis.


Ready to start?

Build a strong foundation using the MRCP Part 1 overview, then test your knowledge with Free MRCP MCQs. When confident, assess your exam readiness through a Start a mock test and refine weak areas with targeted revision.


Sources

 
 
 

Comments

bottom of page